Endocrine and metabolic effects of valproate in premenopausal women with affective psychosis

Trial Profile

Endocrine and metabolic effects of valproate in premenopausal women with affective psychosis

Active, no longer recruiting
Phase of Trial: Clinical Phase Unknown

Latest Information Update: 25 Sep 2006

At a glance

  • Drugs Valproate semisodium (Primary) ; Neuropsychotherapeutics
  • Indications Bipolar disorders; Schizoaffective disorder
  • Focus Adverse reactions
  • Most Recent Events

    • 25 Sep 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top